Epidermal Growth Factor Receptor (egfr) - Pharma

Relevant Publications

Tanreqing injection inhibits stemness and enhances sensitivity of non-small cell lung cancer models to gefitinib through ROS/STAT3 signaling pathway.

Issue Release: 2024

A Visual Analysis of the Research Dynamics in Resistance to EGFR Inhibitors for NSCLC.

Issue Release: 2024

Distinct roles and molecular mechanisms of nicotine and benzo(a)pyrene in ferroptosis of lung adenocarcinoma and lung squamous cell carcinoma.

Issue Release: 2024

The clinical features and prognostic implications of the co-mutated TP53 gene in advanced non-small cell lung cancer.

Issue Release: 2024

Prediction of epidermal growth factor receptor mutation subtypes in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning.

Issue Release: 2024

Discrete placental gene expression signatures accompany diabetic disease classifications during pregnancy.

Issue Release: 2024

The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer.

Issue Release: 2024

Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway.

Issue Release: 2024

Current perspectives of KRAS in non-small cell lung cancer.

Issue Release: 2024

Antitumor activity of afatinib in EGFR T790M-negative human oral cancer therapeutically targets mTOR/Mcl-1 signaling axis.

Issue Release: 2024

Crosstalk of MAP3K1 and EGFR signaling mediates gene-environment interactions that block developmental tissue closure.

Issue Release: 2024

Primary Stereotactic Body Radiotherapy for Spinal Bone Metastases From Lung Adenocarcinoma.

Issue Release: 2024

EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta.

Issue Release: 2024

Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect.

Issue Release: 2024

Analysis of serum proteomic profiles of endangered Siamese and Burmese Eld\'s Deer infected with subclinical Babesia bovis in Thailand.

Issue Release: 2024

Targeted analysis of Ubiquitin-Specific Peptidase (USP8) in a population of Iranian people with Cushing\'s disease and a systematic review of the literature.

Issue Release: 2024

Multifaceted role of erlotinib in various cancer: nanotechnology intervention, patent landscape, and advancements in clinical trials.

Issue Release: 2024

Cancer mutational signatures identification in clinical assays using neural embedding-based representations.

Issue Release: 2024

Comparative effectiveness of lazertinib in patients with EGFR T790M-positive non-small-cell lung cancer using a real-world external control.

Issue Release: 2024

Hepatocyte-macrophage crosstalk via the PGRN-EGFR axis modulates ADAR1-mediated immunity in the liver.

Issue Release: 2024

How Does Pharma Play a Role in Chronic Conditions?

What is an Abbreviated New Drug Application (ANDA)?

What are Collaborative Care Models?

How Does the Patent System Affect Generic Competition?

What Causes Adverse Drug Events?

Why is Patient Education Important?

What Are Clinical Trials?

What is Pharmaceutical Science?

How are ADEs Different from Side Effects?

What is Regulatory Approval?

Partnered Content Networks

Relevant Topics